Verification evidence is still being completed.
PDF / print export
Kalceks
Riga, Latvia
- Verified lead
- Egils Kopstals
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chairman of the Board
- 2026 technical specialization
- Sterile Dosage Forms, Hospital Medicines, and Finished Dosage Manufacturing
- Review cycle
- May 2026
- Full address
- Krustpils iela 71E, Riga, LV-1057, Latvia
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Kalceks homepage confirming the current public leadership in Riga.
- Editorial note
- Kalceks gives the Latvia layer a hospital-focused manufacturing node with a named board lead, a fixed Riga production address, and official GMP-quality language on the company surface.
Sterile Dosage Forms, Hospital Medicines, and Finished Dosage Manufacturing
GMP requirements, ISO certifications, ICH guidelines
Kalceks gives the Latvia layer a hospital-focused manufacturing node with a named board lead, a fixed Riga production address, and official GMP-quality language on the company surface.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Riga, Latvia
Kalceks
Sterile Dosage Forms, Hospital Medicines, and Finished Dosage Manufacturing · International finished-dosage manufacturing
Kalceks gives the Latvia layer a hospital-focused manufacturing node with a named board lead, a fixed Riga production address, and official GMP-quality language on the company surface.
- Lead
- Egils Kopstals (verified ↗)
- Address
- Krustpils iela 71E, Riga, LV-1057, Latvia (source ↗)
- Compliance
- GMP requirements
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- International finished-dosage manufacturing
- Capabilities
- Sterile Dosage Forms · Finished Dosage Form Production · Hospital-Segment Medicines
- Founded
- 1920
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Egils Kopstals
Chairman of the Board
Full addressKrustpils iela 71E, Riga, LV-1057, Latvia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Kalceks contact page listing the Krustpils iela 71E Riga address.
Open sourceInternational finished-dosage manufacturing
Riga, Latvia. Sterile Dosage Forms, Hospital Medicines, and Finished Dosage Manufacturing. Review completed on 21 Mar 2026.
Latvian and EU pharmaceutical manufacturing oversight
GMP requirements, ISO certifications, ICH guidelines
Sterile Dosage Forms, Hospital Medicines, and Finished Dosage Manufacturing
Kalceks gives the Latvia layer a hospital-focused manufacturing node with a named board lead, a fixed Riga production address, and official GMP-quality language on the company surface.
Editorial note
Kalceks gives the Latvia layer a hospital-focused manufacturing node with a named board lead, a fixed Riga production address, and official GMP-quality language on the company surface.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Sterile Dosage Forms
Finished Dosage Form Production
Hospital-Segment Medicines
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Sterile dosage-form production lines
Finished-dose manufacturing infrastructure
Quality and development systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Kalceks located?
- Kalceks operates from Krustpils iela 71E, Riga, LV-1057, Latvia, Riga, Latvia.
- Who runs Kalceks?
- Kalceks is led by Egils Kopstals, Chairman of the Board. Verified 21 Mar 2026.
- What certifications does Kalceks hold?
- Kalceks is documented under GMP requirements.
- What does Kalceks do?
- Kalceks gives the Latvia layer a hospital-focused manufacturing node with a named board lead, a fixed Riga production address, and official GMP-quality language on the company surface. Core capabilities: Sterile Dosage Forms, Finished Dosage Form Production, Hospital-Segment Medicines.
Editorial context
Related technical briefs
Briefs that name Riga as a covered market or city.